- Bullish trend confirmed on both short and long timeframes
- Consistently positive technical signals over the last month
- +59.5% price growth over the last year
Complete Genomics, Inc ETF upgraded to Strong Buy Candidate
(Updated on Jun 18, 2026)
The Complete Genomics, Inc ETF price gained 1.50% on the last trading day (Thursday, 18th Jun 2026), rising from $51.30 to $52.07. During the last trading day the ETF fluctuated 1.52% from a day low at $51.43 to a day high of $52.21. The price has been going up and down for this period, and there has been a 2.68% gain for the last 2 weeks. Volume fell on the last day by -3 thousand shares and in total, 14 thousand shares were bought and sold for approximately $711.18 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The ETF lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $52.10 will firstly indicate a stronger rate of rising. Given the current short-term trend, the ETF is expected to rise 14.81% during the next 3 months and, with a 90% probability hold a price between $52.97 and $59.82 at the end of this 3-month period.
GNOM Signals & Forecast
The Complete Genomics, Inc ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $49.93 and $47.51. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 18.61%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Complete Genomics, Inc ETF
Complete Genomics, Inc finds support from accumulated volume at $50.71 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This ETF has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the ETF moved $0.780 between high and low, or 1.52%. For the last week the ETF has had daily average volatility of 1.85%.
Our recommended stop-loss: $49.49 (-4.95%) (This ETF has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 21 days ago.)
Trading Expectations (GNOM) For The Upcoming Trading Day Of Monday 22nd
For the upcoming trading day on Monday, 22nd we expect Complete Genomics, Inc to open at $51.90, and during the day (based on 14 day Average True Range), to move between $51.46 and $52.68, which gives a possible trading interval of +/-$1.23 (+/-2.38%) up or down from last closing price. If Complete Genomics, Inc takes out the full calculated possible swing range there will be an estimated 2.38% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $50.71, some $1.36 (2.61%) from the current price of $52.07, our system finds the risk reward attractive.
Is Complete Genomics, Inc ETF A Buy?
Complete Genomics, Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this ETF since the last evaluation from a Buy to a Strong Buy candidate.
Current score:
7.116
Strong Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 22, 2026 - $51.90 ( 0.320%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
GNOM Performance
Trading levels for GNOM
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 52.68 | 1.18% |
| R2 | 52.39 | 0.605% |
| R1 | 52.20 | 0.252% |
| Price | 52.07 | |
| S1 | 51.61 | -0.89% |
| S2 | 51.42 | -1.25% |
| S3 | 51.12 | -1.82% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 52.07 | |
| S1 | 50.71 | -2.61% |
| S2 | 49.68 | -4.59% |
| S3 | 43.37 | -16.71% |
GNOM Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Dec 29, 2025 | Dec 30, 2025 | Jan 07, 2026 | $0.591 | 1.21% |
| 2 | Jun 26, 2025 | Jun 27, 2025 | Jul 07, 2025 | $0.0083 | 0.0242% |
| 3 | Dec 29, 2021 | Dec 30, 2021 | Jan 07, 2022 | $0.0280 | 0.0393% |
| 4 | Dec 29, 2020 | Dec 30, 2020 | Jan 08, 2021 | $0.128 | 0.124% |
FAQ
Click here for our free guide on how to buy Complete Genomics, Inc ETF.
Buy GNOM
A buy signal from a double bottom formation was found on Tuesday, May 19, 2026 with a target of $48.35. Despite whether the objective of the signal formation has been reached the ETF may continue to perform well.